Theragnostics in Thyroid Cancer and Neuroendocrine Tumors
Theragnostics in Thyroid Cancer and Neuroendocrine Tumors –
The Experience of the University of Michigan
Prof. Avram is a world leader in the therapy of patients with endocrine tumors. She will present their data on clinical outcome for patients with advanced thyroid cancer, and discuss 68Ga-DOTATATE PET/CT imaging and 177Lu-DOTATATE as a therapeutic agent in patients with neuroendocrine tumors.